Navigation Links
Onyx Pharmaceuticals Names John E. Osborn Senior Vice President, Global Corporate Affairs
Date:7/9/2012

SOUTH SAN FRANCISCO, Calif., July 9, 2012 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (NASDAQ:   ONXX) today announced that it has appointed John E. Osborn as Senior Vice President, Global Corporate Affairs.  In his role, Mr. Osborn will report to N. Anthony Coles, M.D., President and Chief Executive Officer, and will be responsible for the public and government affairs activities of the company, as well as key stakeholder relationships.

"As a lawyer, policy advocate and former diplomat, John brings a diverse and extensive background to Onyx, with broad experience across the life sciences industry and the U.S. government," said Dr. Coles.  "John is a proven leader and his unique expertise aligns well with our plan for global growth as a multi-product company reaching patients around the world."

Prior to joining Onyx, Mr. Osborn was Executive Vice President, General Counsel and Secretary at Dendreon Corporation.  Previously, he held similar roles at US Oncology, Inc., where he worked on its merger with McKesson, and at Cephalon, Inc., where he managed legal, public and government affairs during a critical growth period.  Mr. Osborn also served with the U.S. Department of State during the George H.W. Bush administration, and in 2008 was confirmed by the Senate as a member of the bipartisan United States Advisory Commission on Public Diplomacy.  He has held faculty appointments at Oxford, Princeton and the University of Washington, served on the board of governors of the East-West Center in Hawaii, and examined the peace process in Northern Ireland as an Eisenhower Fellow.  Early in his career he clerked for Judge Albert V. Bryan of the U.S. Court of Appeals for the Fourth Circuit, and practiced corporate law in Boston for Hale and Dorr (now WilmerHale).  Mr. Osborn received his undergraduate degree in economics and history from the University of Iowa, his law degree from the University of Virginia School of
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Inovio Pharmaceuticals to Present at JMP Investor Conference
2. Inspiration Biopharmaceuticals Reports Positive Interim Results from the Accur8 Phase 2/3 Study of OBI-1 in Acquired Hemophilia A at WFH 2012 World Congress
3. Vanda Pharmaceuticals to Present at the JMP Securities Healthcare Conference
4. Amgen Completes Acquisition of KAI Pharmaceuticals
5. Optimer Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
6. Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs
7. Isis Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
8. Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.
9. The Leukemia & Lymphoma Society and Celator Pharmaceuticals Announce $5 Million Partnership to Support Phase 3 Development of CPX-351 for AML
10. Amylin Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Bristol-Myers Squibb Company
11. Nouveau Life Pharmaceuticals (NOUV) In Talks with International Mass Distribution Firms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... ALBANY, New York , September 30, 2014 /PRNewswire/ ... Market - Global Industry Analysis, Market Size, Share, Growth ... Research is expected to be worth USD 20.8 billion ... 29.5 billion in 2017, growing at a CAGR of ... are fundamental elements needed for various health purposes, especially ...
(Date:9/30/2014)...   Decision Resources Group finds that through ... kidney disease non-dialysis (CKD-ND) patients are not highly ... addition, one-year persistency is similar between Amgen,s Aranesp ... findings from the report entitled Treatment ... Agents in Late Stage Chronic Kidney Disease and ...
(Date:9/30/2014)... SAN DIEGO , 30. September ... Logo - http://photos.prnewswire.com/prnh/20130430/LA01948LOGO ... ein Medizintechnikunternehmen, das ein minimal-invasives 3D-Herzkammer-Bildgebungs- ... der Ursachen entwickelt, die zu komplexen ... aufrechterhalten, hat den Abschluss einer zusätzlichen ...
Breaking Medicine Technology:Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 2Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 3Nutraceutical Ingredient Market Will Reach USD 33.6 Billion Globally in 2018: Transparency Market Research 4Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents 2Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents 3Acutus Medical, Inc. schließt zusätzliche Finanzierungsrunde Serie B über 26,2 Mio. USD ab, um Portfolio-Erweiterung zu finanzieren 2Acutus Medical, Inc. schließt zusätzliche Finanzierungsrunde Serie B über 26,2 Mio. USD ab, um Portfolio-Erweiterung zu finanzieren 3
... InteKrin Therapeutics, Inc., a clinical stage biopharmaceutical company ... has completed enrollment of a 360 patient Phase 2b ... PPAR gamma (SPPARM) for the treatment of Type 2 ... dose active comparator (45mg Actos(R)) and placebo controlled study ...
... the nation,s economic slowdown, America,s pharmaceutical research and ... year in the research and development of new ... roughly $2 billion from 2007, according to analyses ... (PhRMA) and Burrill & Company. PhRMA-member companies ...
Cached Medicine Technology:InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study 2R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges 2R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges 3R&D Spending by U.S. Biopharmaceutical Companies Reaches Record Levels in 2008 Despite Economic Challenges 4
(Date:9/30/2014)... HealthDay Reporter TUESDAY, Sept. 30, ... to put the brakes on motherhood. And for many young ... choice, new research suggests. Women in their early 20s ... during tough economic times. But, according to the new study, ... their 40s and beyond. The findings suggest that higher ...
(Date:9/30/2014)... the leading cause of cancer death in women, according ... medical professionals encourage women to get mammograms, even though ... of suspicious mammograms actually leads to a cancer diagnosis. ... women and their familiesnot to mention the time, discomfort ... , Recently, a different type of test, ultrasound ...
(Date:9/30/2014)... Dynamic health trends, changing consumer ... the Bread Production industry over the past five ... their consumption of a variety of industry goods ... the market for white loaf bread and other ... introducing more nutritious products to attract health-conscious consumers, ...
(Date:9/30/2014)... of Maryland-led research team has been awarded a ... of Health (NIH) to develop new imaging technologies ... understanding of how large networks of neurons in ... knowledge will help researchers identify the precise interactions ... like decision-making and speaking, and alterations in these ...
(Date:9/30/2014)... September 30, 2014 The American ... to help diabetics curb their sweet tooth, but the ... this September, suggests that zero-calorie sweeteners may actually ... diabetes. , The Weizmann Institute of Science in ... artificial sweeteners to mice, the mice developed glucose intolerance. ...
Breaking Medicine News(10 mins):Health News:Recessions May Thwart a Woman's Motherhood Plans Forever: Study 2Health News:Recessions May Thwart a Woman's Motherhood Plans Forever: Study 3Health News:'Virtual breast' could improve cancer detection 2Health News:Bread Production in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Bread Production in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:UMD receives inaugural BRAIN Initiative Award 2Health News:Artificial Sweeteners May be Linked to Greater Diabetes Risk 2
... Though nursing is thought to reduce risk, more advanced tumors ... Women who breast-feed for six months or more face a ... cancer, but it,s not clear whether there,s a cause-and-effect relationship, ... these women are more likely to die of cancer than ...
... ... Experience in Style , ... March 26, 2010 -- Last week EarPeace provided hearing protection to thousands of music ... bands over the course of four days. The average decibel level at a concert is ...
... ... local and national organizations to help individuals in need. , ... Munster, IN (PRWEB) March 26, 2010 -- ... its efforts in giving back to the community and helping individuals in need of ...
... alcohol use tied to better lifestyle habits, study finds ... take worse care of themselves than other people, but ... who don,t imbibe, researchers have found. , "The main ... other behaviors -- such as relieving stress with alcohol ...
... beta-blockers can help reduce the spread of cancer in ... seventh European Breast Cancer Conference (EBCC7) in Barcelona today ... senior healthcare research scientist at Queen,s Medical Centre, Nottingham ... found that the group of patients treated with beta-blockers ...
... Spain: Two studies to be presented at the seventh ... and tomorrow (Saturday), shed light on the treatment options ... which predispose them to breast cancer. In the first, ... of Medical Oncology, Erasmus Medical Centre, Rotterdam, The Netherlands, ...
Cached Medicine News:Health News:Long-Term Breast-Feeding Tied to More Aggressive Cancers 2Health News:EarPeace Protects Hearing for Thousands at South by Southwest 2Health News:Stirling Dental Laboratory, Experts in Emergency Denture Repair Service, Gives Back to Community 2Health News:Stirling Dental Laboratory, Experts in Emergency Denture Repair Service, Gives Back to Community 3Health News:Heavy Daily Drinking Linked to Worse Health 2Health News:Beta-blockers help reduce metastasis and improve survival in breast cancer patients 2Health News:New studies on surgical options in inherited breast cancer show drastic treatment is not always best 2Health News:New studies on surgical options in inherited breast cancer show drastic treatment is not always best 3Health News:New studies on surgical options in inherited breast cancer show drastic treatment is not always best 4
Solid State Manometry Catheter Accessory., ,Manometric calibrators are required for calibration of solid state catheters., ,Each type of catheter requires a unique calibrator....
Sphincter of Oddi Solid State Catheter Adapter Cable for Polygraf ID...
... The ITREL 3 is a battery powered ... the U.S., ,Enterra™ Therapy is indicated ... vomiting associated with gastroparesis when conventional drug ... symptons for diabetic or idiopathic patients., ...
... rapid qualitative test for detection of cardiac ... samples. It can be used as an ... and can be useful to assess if ... angina (e.g. gastric pain, strained chest muscles, ...
Medicine Products: